skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
previous page 1 Resultados 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: AUC Wiley Frozen Package in 2012 remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide
Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide
Material Type:
Artigo 		Adicionar ao Meu Espaço

Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide

Fong, Tse‐Ling ; Lee, Brian T. ; Tien, Andy ; Chang, Mimi ; Lim, Carolina ; Ahn, Aiden ; Bae, Ho S.

Journal of viral hepatitis, 2019-05, Vol.26 (5), p.561-567 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
12
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models

De Sousa Mendes, Maïlys ; Hirt, Deborah ; Vinot, Cécile ; Valade, Elodie ; Lui, Gabrielle ; Pressiat, Claire ; Bouazza, Naïm ; Foissac, Frantz ; Blanche, Stephane ; Lê, Minh Patrick ; Peytavin, Gilles ; Treluyer, Jean‐Marc ; Urien, Saik ; Benaboud, Sihem

British journal of clinical pharmacology, 2016-04, Vol.81 (4), p.646-657 [Periódico revisado por pares]

England: John Wiley and Sons Inc

Texto completo disponível

Citações Citado por
13
Review of Real‐World Implementation Data on Emtricitabine‐Tenofovir Disoproxil Fumarate as HIV Pre‐exposure Prophylaxis in the United States
Review of Real‐World Implementation Data on Emtricitabine‐Tenofovir Disoproxil Fumarate as HIV Pre‐exposure Prophylaxis in the United States
Material Type:
Artigo 		Adicionar ao Meu Espaço

Review of Real‐World Implementation Data on Emtricitabine‐Tenofovir Disoproxil Fumarate as HIV Pre‐exposure Prophylaxis in the United States

Adams, Jessica L. ; Shelley, Karishma ; Nicol, Melanie R.

Pharmacotherapy, 2019-04, Vol.39 (4), p.486-500 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
14
Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B

Kim, W. Ray ; Loomba, Rohit ; Berg, Thomas ; Aguilar Schall, Raul E. ; Yee, Leland J. ; Dinh, Phillip V. ; Flaherty, John F. ; Martins, Eduardo B. ; Therneau, Terry M. ; Jacobson, Ira ; Fung, Scott ; Gurel, Selim ; Buti, Maria ; Marcellin, Patrick

Cancer, 2015-10, Vol.121 (20), p.3631-3638 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
15
Effects of Prolonged Administration of Tenofovir Disoproxil Fumarate‐Containing Antiviral Regimen on Renal Function in Low‐Risk of Kidney Injury HIV Patients
Effects of Prolonged Administration of Tenofovir Disoproxil Fumarate‐Containing Antiviral Regimen on Renal Function in Low‐Risk of Kidney Injury HIV Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of Prolonged Administration of Tenofovir Disoproxil Fumarate‐Containing Antiviral Regimen on Renal Function in Low‐Risk of Kidney Injury HIV Patients

Yuan, Yuan ; He, Shenghua ; Liu, Huanxia ; He, Yuanhong ; Zhou, Ruifeng ; Yao, Yuan ; Yin, Ke ; Lyu, Chunrong

Journal of clinical pharmacology, 2024-05, Vol.64 (5), p.626-633 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
16
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B

Ogawa, Eiichi ; Nomura, Hideyuki ; Nakamuta, Makoto ; Furusyo, Norihiro ; Koyanagi, Toshimasa ; Dohmen, Kazufumi ; Ooho, Aritsune ; Satoh, Takeaki ; Kawano, Akira ; Kajiwara, Eiji ; Takahashi, Kazuhiro ; Azuma, Koichi ; Kato, Masaki ; Shimoda, Shinji ; Hayashi, Jun

Liver international, 2020-07, Vol.40 (7), p.1578-1589 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
17
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study

Baldin, G ; Ciccullo, A ; Capetti, A ; Rusconi, S ; Sterrantino, G ; Cossu, MV ; Giacomelli, A ; Lagi, F ; Latini, A ; Bagella, P ; De Luca, A ; Di Giambenedetto, S ; Madeddu, G

HIV medicine, 2019-02, Vol.20 (2), p.164-168 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
18
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine

Cid‐Silva, Purificación ; Fernández‐Bargiela, Noelia ; Margusino‐Framiñán, Luis ; Balboa‐Barreiro, Vanesa ; Mena‐De‐Cea, Álvaro ; López‐Calvo, Soledad ; Vázquez‐Rodríguez, Pilar ; Martín‐Herranz, Isabel ; Míguez‐Rey, Enrique ; Poveda, Eva ; Castro‐Iglesias, Ángeles

Basic & clinical pharmacology & toxicology, 2019-04, Vol.124 (4), p.479-490 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
19
Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B
Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B
Material Type:
Artigo 		Adicionar ao Meu Espaço

Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B

Cheng, Pin‐Nan ; Feng, I‐Cher ; Chen, Jyh‐Jou ; Kuo, Hsing‐Tao ; Lee, Pei‐Lun ; Yu, Ming‐Lung ; Chiu, Yen‐Cheng ; Chiu, Hung‐Chih ; Chien, Shih‐Chieh ; Chen, Pei‐Jer ; Liu, Chun‐Jen

Alimentary pharmacology & therapeutics, 2024-01, Vol.59 (2), p.230-238 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
20
Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy
Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy

Su, Jia‐Yong ; Wu, Ying‐Ling ; Wu, Xuan‐Lin ; Liu, Zhen‐Xiu ; Wang, Yi‐Yang ; Li, Zhong‐Hai ; Luo, Jia‐Xin ; Wu, Kun‐Jun ; Zhong, Jian‐Hong

Alimentary pharmacology & therapeutics, 2023-10, Vol.58 (8), p.842-844 [Periódico revisado por pares]

Chichester: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (814)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (814)
  2. Reports  (6)
  3. Newsletter Articles  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2004  (11)
  2. 2004Até2008  (67)
  3. 2009Até2013  (136)
  4. 2014Até2019  (290)
  5. Após 2019  (318)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.